, welcome to your FemTech II Fund Dashboard!

Portfolia’s 2024 Performance Reports are now available for all funds. COO Tammi Jantzen will present an overview April 3rd on Understanding Performance Reports and K-1s. Register Now to secure your spot.

Live and interactive meetings will be held for Fund Members with Fund management teams from April 20 to May 15. Stay tuned for detailed schedules.

Join the Waitlist

The Portfolia Investor Summit has officially reached capacity. If you’d like to join us, please add your information below. We will be in touch if space becomes available.

Join the Waitlist

As we focus on performance, the Rising America Funds continue to be among our highest performers with Fund I in the top 5% of all venture capital funds of its vintage year. With a strong focus in healthcare and fintech, secure your spot now in Rising America Fund III.

FemTech Fund II is currently at 0.79x net TPVI, meaning every $1 invested by the fund is worth $0.79. Portfolia's dedicated healthcare funds operate on a longer development and return cycle due to the nature of the sector. Unlike other areas of venture investing, healthcare companies must navigate rigorous safety and efficacy standards, including FDA regulatory trials and approval processes. While enterprise and technology investments may fail to meet expectations as a natural part of venture risk, setbacks in healthcare can have far-reaching consequences, potentially delaying critical treatments or life-saving innovations. With 16 active companies in FemTech Fund II, including Everly Health and Bone Health Technologies, we expect to see significant future distributions from the fund.

Annual Fund Performance Report

2024 FemTech II Fund Performance Updates

The 2024 financial statements are as of and for December 31, 2024. Please note all updates provided are confidential and not for distribution.

To access, use password: 2024FT2Report!

ACCESS THE REPORT

Quarterly Reports

The highlights of Q4 2024 updates as provided by the company. Please note all updates provided are confidential and not for distribution.

To access the file, use password: Q424FT2!

ACCESS THE REPORT

FemTech II Portfolio Highlights

The Companies & Leadership Team

The Portfolia FemTech II Fund is led by a world-class team of highly sophisticated and experienced investors who are leaders in their respective fields, as venture capitalists, angel investors, and innovators. They bring an expert skill-set including sourcing, diligence, deal negotiation, executive recruitment, strategy and governance. Click on photos for full bios.

The Companies

Company Logo Gallery

Joylux

Joylux is a health and wellness company that creates innovative, high-quality, safe, natural, and efficacious intimate health solutions that improve the quality of life in peri/post-menopausal women.

Madorra

Madorra has developed the first effective, non- hormonal treatment and new treatment paradigm for vaginal dryness.

Madison Reed

Madison Reed is a beauty company revolutionizing the way women color their hair.

Aria CV

A medical device company treating pulmonary arterial hypertension (PAH) by developing ways to enhance both the survival and quality of life of those with PAH.

Bone Health Technologies

Leveraging NASA research to develop a wearable medical device that is tackling an epidemic of low bone mass - osteopenia (moderate bone loss) and osteoporosis (severe bone loss).

Everly Health

Offering at-home lab testing kits to make insightful testing and virtual care accessible to all, including its FDA-authorized Covid-19 Test Home Collection kit‎‏‏‎ ‎‏‏‎ ‎‏‏‎ ‎‏‏‎ ‎‏‏‎ ‎‏‏‎

Nest Collaborative

Nest Collaborative is a provider of on-demand lactation counseling services intended to offer international board-certified lactation consultants who conduct online video appointments, guiding moms through the breastfeeding process.

YourChoice

A non-hormonal contraceptive designed to eliminate the risk of negative side effects associated with traditional hormonal contraceptives.

Aeena

Developer of medical testing kits designed to offer diagnostics testing in less time.

Attn: Grace

Attn Grace is a sustainable wellness brand designed for women, creating more sustainable solutions for women to combat bladder leakage.

Willow

Willow develops an in-bra wearable breast pump that is cordless and spill-proof. This also tracks milk output through a mobile app and online portal allowing for mothers to pump anywhere without hassle.

Hey Jane

A digital clinic intended to provide women access to abortion pills. The company also offers services such as arranging consultations with licensed medical practioners, providing home delivery of prescribed medications, enabling women with an effective solution for at-home abortions, and increasing reproductive health equity.

Inherent Biosciences

A molecular diagnostics company at the intersection of epigenetics and AI tackling clinical problems where epigenetics appears to be involved such as infertility.

Proov

Patented, at-home testing system for fertility and hormone level insights.

Rosy Wellness

Developer of a subscription-based sexual wellness application intended to address sexual problems and questions.

xCures

xCures is a provider of a patient-centric AI-based virtual trial software intended to support advanced cancer patients and their doctors with evidence-based treatment options.